ANO1 and cancer: Several studies have shown that TMEM16A overexpression is closely associated with cell proliferation, metastasis, and apoptotic sensitivity in cancer tissues (20, 21, 22); therefore, inhibiting the TMEM16A function may be beneficial in treating related cancers (11, 12).